CAMBRIDGE, Mass., June 5, 2024 /PRNewswire/ — Regor Therapeutics Group, a clinical-stage global biopharmaceutical company, today announced the Company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Thursday, June 12. Dr. Xiayang Qiu, Founder and CEO,…
Mi piace:
Mi piace Caricamento...
